I. Basic Overview of the Hospital

Geographical Location and Environmental Background

Country and City Location: The hospital is situated in the Pulvorak District of downtown Bishkek, the capital of Kyrgyzstan. Located in the core urban area, it boasts well-developed surrounding facilities, adjacent to a national botanical garden, 1 public general hospital, 2 foreign-related hotels, and 2 Chinese restaurants, providing convenient living and medical support.

Urban Environment: Bishkek, the political, economic, and cultural hub of Kyrgyzstan, covers an area of 130 square kilometers with a population of approximately 1.2 million. The average temperature in January is -4.7℃, and 24.5℃ in July. Nestled at the foot of the Tianshan Mountains, the city blends nomadic traditions with modern vitality. Boasting no heavy industry and being far from pollution sources, Kyrgyzstan features pure water and soil. Additionally, the local traditional customs value women’s childbirth, earning it the title of “a natural sacred land for nurturing life.”

Hospital Hardware and Department Setup

Scale and Facilities: The hospital spans 4 floors with a total area of over 1,800 square meters. Constructed in strict compliance with international advanced IVF reproductive center standards, it operates on self-owned property.

Departments and Service Closed-Loop: Equipped with comprehensive departments including consulting rooms, clinical laboratories, imaging departments, operating rooms, embryo laboratories, injection rooms, and genetic testing laboratories, the hospital provides one-stop reproductive medical services covering precise testing, efficient treatment, embryo cultivation, and genetic screening.

Core Medical Team Information

Chief Scientist & Medical Director: Yang Zhihong

Professional Background: Professor and Doctoral Supervisor with over 30 years of study and work experience in assisted reproductive technology (ART) in the United States and Canada. He previously served as a Full Clinical Professor at the University of Pittsburgh School of Medicine and Director of the Laboratory of Andrology, Embryology, and Endocrinology at the university’s medical center.

Academic Achievements: Co-founder and Secretary-General of the International Society of Reproductive Genetics (ISRG), Co-Chair of the Preimplantation Genetic Diagnosis International Society (PGDIS), and Editorial Board Member of the Journal of Assisted Reproduction and Genetics (JARG). In 2012, he published the world’s first prospective sampling clinical study on comprehensive chromosomal PGT-T, laying the foundation for the clinical application of 24sure comprehensive chromosomal PGT-T. In 2014, he took the lead in publishing the world’s first randomized sampling clinical study on the combined application of Time-lapse and PGT-A technologies, pioneering the combined use of related technologies.

Embryology (TL), and R&D and application of assisted reproductive technologies.

Clinical Director: Li Bo

Professional Background:Master of Medicine, Associate Chief Physician, graduated with a master’s degree from Shandong University, with over 20 years of working experience in the reproductive center of a top-tier Grade A hospital in China.

Clinical Competence:
Proficient in the entire process of In Vitro Fertilization and Embryo Transfer (IVF-ET), including patient screening and evaluation, controlled ovarian hyperstimulation, oocyte retrieval, embryo transfer, luteal phase support after transfer, and multifetal pregnancy reduction; skilled in reproductive endocrine regulation, management of assisted reproductive-related complications, and hysteroscopic and laparoscopic surgeries for uterine and adnexal diseases in reproductive medicine.

Academic Achievements:
Published 4 SCI papers and 12 national core journal papers; presided over 2 provincial-level and 2 municipal-level research projects; won a total of 4 provincial and municipal Science and Technology Awards.

Hospital’s Distinctive Advantages

Technological and Equipment Advantages

Core Equipment Configuration:

Introduced Vitrolife Eppendorf Time-lapse Incubator (EmbryoScope+ time-lapse system), providing optimal embryo culture conditions while recording embryo development images;

Equipped with GE E8 B-ultrasound machine (USA), with invited Chinese imaging experts supporting 4D ultrasound and fetal echocardiography;

Owned Roche Cobas e411 fully automatic chemiluminescence immunoassay analyzer, ensuring timely and accurate hormone testing;

Established a professional genetic testing laboratory, capable of conducting PGD (Preimplantation Genetic Diagnosis), non-invasive prenatal DNA testing, fetal paternity testing, and neonatal paternity testing;

Adopted Swiss-standard IVF workstations, featuring multi-zone heating, integrated microscopy, monitoring, and gas humidification systems, with additional safety protection based on top-tier laboratory purification standards.

Technological Philosophy:
Adheres to international cutting-edge diagnosis and treatment protocols, emphasizing technological innovation (e.g., combined application of Time-lapse and PGT-A technologies) to improve embryo selection and implantation success rates.

Operational and Service Advantages

Compliance and Stability:
Founded by investors with nearly 20 years of experience in the entire assisted reproductive industry chain, featuring a simple equity structure and efficient decision-making; owns property to avoid rental risks, ensuring stable operations; equipped with full-time legal and financial teams to ensure compliance with Kyrgyzstan’s laws and provide legal protection for clients.

Privacy Protection:
Established strict information security systems with dual safeguards to ensure client privacy and confidentiality.

One-stop Service:
Provides end-to-end services from fertility consultation, indicator testing, biological sample collection, and signing in Kyrgyzstan, to embryo culture and testing, surrogate mother selection (if needed), pregnancy management, and finally to baby delivery, document processing, and return to China—eliminating the need for clients to coordinate with multiple parties.

Multilingual and Localization Support:
Adopts a “Chinese medical team-led + local operation team + professional translation team” model to address language barriers and local affairs handling; establishes strategic cooperation with local business companies, notary offices, and certification authorities to provide legal support for client travel and newborn repatriation.

Policy and Environmental Advantages

Local Policy Support:
According to the “Law of the Kyrgyz Republic on the Protection of Citizens’ Health” and Cabinet Resolution No. 616 dated October 14, 2024, assisted reproductive technologies (including artificial insemination, embryo transfer, use of donated and frozen gametes/embryos, and surrogacy) are legal. Both married and unmarried individuals have the right to use these technologies on a voluntary and informed basis, with highly inclusive policies.

International Cooperation Background:
Collaborates with the International Society of Reproductive Genetics (ISRG) to align with international advanced reproductive medical standards and promote the standardization of technologies and services.

Target Groups and Service Process

Target Groups

According to the hospital’s public information, the main service groups include:

Advanced-age fertility seekers;

Individuals seeking gender selection;

Groups with fertility disorders (requiring assistance through genetic testing and other technologies);

Families who have lost their only child;

LGBTQ+ groups;

Fertility preservation seekers (e.g., those needing oocyte or embryo freezing).

Core Service Process

Pre-consultation and Preparation: Exclusive one-on-one fertility consultation → Fertility indicator testing → Signing in China → Document processing;

Travel to Kyrgyzstan and Project Launch: Biological sample collection → Signing in Kyrgyzstan → Initiation of assisted reproductive project;

Medical Treatment and Pregnancy Management: Embryo culture and testing → Surrogate mother selection (if needed) → Full-cycle pregnancy management;

Postpartum and Return to China: Baby delivery → Processing of newborn documents → Baby’s return to China.

Social Responsibility and Academic Participation

Employment and Public Welfare:
Creates employment opportunities for local residents in Kyrgyzstan with competitive salaries during operations; participates in public welfare activities to fulfill corporate social responsibility.

Medical Exchange and Improvement:
Actively cooperates with Kyrgyzstan’s obstetrics and gynecology sector, introducing Chinese diagnostic technologies and medical talents; participates in local obstetrics and gynecology academic seminars to contribute to the development of maternal and child health in Kyrgyzstan.